A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
NCT00203008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2106
Last updated 2010-10-18
Summary
Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.
Conditions
- Parkinson's Disease
- Malignant Melanoma
Sponsors & Collaborators
-
Teva Branded Pharmaceutical Products R&D, Inc.
lead INDUSTRY
Principal Investigators
-
Bruce Schwartz, Ph.D. · Teva Neuroscience, Inc.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2003-09-30
More Related Trials
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948 ·Status: COMPLETED ·Phase: NA
-
The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy
NCT00237965 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination
NCT01432860 ·Status: COMPLETED ·Phase: NA
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING
-
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013 ·Status: RECRUITING ·Phase: PHASE3
-
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
NCT02858869 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
NCT02723006 ·Status: TERMINATED ·Phase: PHASE1
-
Taxoprexin® Treatment for Advanced Eye Melanoma
NCT00244816 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.
NCT02009085 ·Status: COMPLETED
-
Intratumoral Administration of L19IL2/L19TNF
NCT02076633 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma
NCT02306850 ·Status: COMPLETED ·Phase: PHASE2
-
DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years
NCT04563949 ·Status: COMPLETED
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA
-
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
NCT00416988 ·Status: COMPLETED ·Phase: NA
-
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
NCT02581930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
NCT01118832 ·Status: COMPLETED
-
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
NCT00087776 ·Status: TERMINATED ·Phase: PHASE3
-
Digital vs. Printed Photographs: Impact on Skin Self-Examinations
NCT02520622 ·Status: COMPLETED ·Phase: NA
-
Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners
NCT02854657 ·Status: COMPLETED ·Phase: NA
-
Long-term Data Collection for Subjects in MDX-010 Studies
NCT00928031 ·Status: COMPLETED
-
Use of 852A in Metastatic Cutaneous Melanoma.
NCT00189332 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin
NCT01085396 ·Status: TERMINATED
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED